Hospital operator HCA Healthcare (NYSE:HCA) will be reporting results this Friday before market hours. Here’s what to look for.
HCA Healthcare beat analysts’ revenue expectations by 0.7% last quarter, reporting revenues of $18.61 billion, up 6.4% year on year. It was a satisfactory quarter for the company, with a solid beat of analysts’ full-year EPS guidance estimates but a slight miss of analysts’ same-store sales estimates.
Is HCA Healthcare a buy or sell going into earnings? Read our full analysis here, it’s free for active Edge members.
This quarter, analysts are expecting HCA Healthcare’s revenue to grow 6.1% year on year to $18.55 billion, slowing from the 7.9% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $5.73 per share.HCA Healthcare Total Revenue
Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. HCA Healthcare has only missed Wall Street’s revenue estimates once over the last two years, exceeding top-line expectations by 1.8% on average.
Looking at HCA Healthcare’s peers in the healthcare providers & services segment, some have already reported their Q3 results, giving us a hint as to what we can expect. Quest delivered year-on-year revenue growth of 13.2%, beating analysts’ expectations by 3.3%, and Elevance Health reported revenues up 11%, in line with consensus estimates. Quest traded down 4.9% following the results while Elevance Health was also down 2.5%.
Read our full analysis of Quest’s results here and Elevance Health’s results here.
There has been positive sentiment among investors in the healthcare providers & services segment, with share prices up 5.5% on average over the last month. HCA Healthcare is up 7.7% during the same time and is heading into earnings with an average analyst price target of $423.95 (compared to the current share price of $441.18).
Today’s young investors likely haven’t read the timeless lessons in Gorilla Game: Picking Winners In High Technology because it was written more than 20 years ago when Microsoft and Apple were first establishing their supremacy. But if we apply the same principles, then enterprise software stocks leveraging their own generative AI capabilities may well be the Gorillas of the future. So, in that spirit, we are excited to present our Special Free Report on a profitable, fast-growing enterprise software stock that is already riding the automation wave and looking to catch the generative AI next.
StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.
View Comments
HCA Healthcare (HCA) Q3 Earnings: What To Expect
Published 2 weeks ago
Oct 23, 2025 at 3:01 AM
Positive
Auto